The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
In the latest session, 2seventy bio Inc (NASDAQ: TSVT) closed at $4.52 down -2.59% from its previous closing price of $4.64. In other words, the price has decreased by -$2.59 from its previous closing price. On the day, 0.61 million shares were traded. TSVT stock price reached its highest trading level at $4.7599 during the session, while it also had its lowest trading level at $4.455.
Ratios:
For a deeper understanding of 2seventy bio Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.98 and its Current Ratio is at 3.98. In the meantime, Its Debt-to-Equity ratio is 1.01 whereas as Long-Term Debt/Eq ratio is at 0.96.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Leerink Partners on January 31, 2024, Upgraded its rating to Outperform and sets its target price to $18 from $5 previously.
Leerink Partners Downgraded its Outperform to Market Perform on October 30, 2023, while the target price for the stock was maintained at $6.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Mar 26 ’24 when Casdin Capital, LLC bought 40,000 shares for $5.10 per share. The transaction valued at 203,992 led to the insider holds 2,000,000 shares of the business.
Casdin Capital, LLC bought 330,000 shares of TSVT for $1,673,991 on Mar 25 ’24. The Director now owns 1,960,000 shares after completing the transaction at $5.07 per share. On Mar 22 ’24, another insider, Casdin Capital, LLC, who serves as the Director of the company, bought 147,377 shares for $5.12 each. As a result, the insider paid 754,069 and bolstered with 1,630,000 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TSVT now has a Market Capitalization of 231926176 and an Enterprise Value of 271610304. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.31 while its Price-to-Book (P/B) ratio in mrq is 0.90. Its current Enterprise Value per Revenue stands at 2.706 whereas that against EBITDA is -1.316.
Stock Price History:
Over the past 52 weeks, TSVT has reached a high of $12.69, while it has fallen to a 52-week low of $1.53. The 50-Day Moving Average of the stock is -13.26%, while the 200-Day Moving Average is calculated to be -5.42%.
Shares Statistics:
For the past three months, TSVT has traded an average of 1.46M shares per day and 898080 over the past ten days. A total of 50.63M shares are outstanding, with a floating share count of 47.64M. Insiders hold about 7.16% of the company’s shares, while institutions hold 93.41% stake in the company. Shares short for TSVT as of 1711584000 were 6806342 with a Short Ratio of 4.67, compared to 1709164800 on 5591013. Therefore, it implies a Short% of Shares Outstanding of 6806342 and a Short% of Float of 13.420000000000002.
Earnings Estimates
The market rating of 2seventy bio Inc (TSVT) is currently shaped by the ongoing analysis conducted by T-REX 2X Long Tesla Daily Targe analysts closely monitoring its performance.The consensus estimate for the next quarter is $4.52, with high estimates of $11.75 and low estimates of $7.64.
